Cargando…

Risk of thrombotic complications in influenza versus COVID‐19 hospitalized patients

BACKGROUND: Whereas accumulating studies on patients with coronavirus disease 2019 (COVID‐19) report high incidences of thrombotic complications, large studies on clinically relevant thrombosis in patients with other respiratory tract infections are lacking. How this high risk in COVID‐19 patients c...

Descripción completa

Detalles Bibliográficos
Autores principales: Stals, Milou A. M., Grootenboers, Marco J. J. H., van Guldener, Coen, Kaptein, Fleur H. J., Braken, Sander J. E., Chen, Qingui, Chu, Gordon, van Driel, Erik M., Iglesias del Sol, Antonio, de Jonge, Evert, Kant, K. Merijn, Pals, Fleur, Toorop, Myrthe M. A., Cannegieter, Suzanne C., Klok, Frederikus A., Huisman, Menno V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8014477/
https://www.ncbi.nlm.nih.gov/pubmed/33821230
http://dx.doi.org/10.1002/rth2.12496
_version_ 1783673560476155904
author Stals, Milou A. M.
Grootenboers, Marco J. J. H.
van Guldener, Coen
Kaptein, Fleur H. J.
Braken, Sander J. E.
Chen, Qingui
Chu, Gordon
van Driel, Erik M.
Iglesias del Sol, Antonio
de Jonge, Evert
Kant, K. Merijn
Pals, Fleur
Toorop, Myrthe M. A.
Cannegieter, Suzanne C.
Klok, Frederikus A.
Huisman, Menno V.
author_facet Stals, Milou A. M.
Grootenboers, Marco J. J. H.
van Guldener, Coen
Kaptein, Fleur H. J.
Braken, Sander J. E.
Chen, Qingui
Chu, Gordon
van Driel, Erik M.
Iglesias del Sol, Antonio
de Jonge, Evert
Kant, K. Merijn
Pals, Fleur
Toorop, Myrthe M. A.
Cannegieter, Suzanne C.
Klok, Frederikus A.
Huisman, Menno V.
author_sort Stals, Milou A. M.
collection PubMed
description BACKGROUND: Whereas accumulating studies on patients with coronavirus disease 2019 (COVID‐19) report high incidences of thrombotic complications, large studies on clinically relevant thrombosis in patients with other respiratory tract infections are lacking. How this high risk in COVID‐19 patients compares to those observed in hospitalized patients with other viral pneumonias such as influenza is unknown. OBJECTIVES: To assess the incidence of venous and arterial thrombotic complications in hospitalized patients with influenza as opposed to that observed in hospitalized patients with COVID‐19. METHODS: This was a retrospective cohort study; we used data from Statistics Netherlands (study period: 2018) on thrombotic complications in hospitalized patients with influenza. In parallel, we assessed the cumulative incidence of thrombotic complications—adjusted for competing risk of death—in patients with COVID‐19 in three Dutch hospitals (February 24 to April 26, 2020). RESULTS: Of the 13 217 hospitalized patients with influenza, 437 (3.3%) were diagnosed with thrombotic complications, versus 66 (11%) of the 579 hospitalized patients with COVID‐19. The 30‐day cumulative incidence of any thrombotic complication in influenza was 11% (95% confidence interval [CI], 9.4–12) versus 25% (95% CI, 18–32) in COVID‐19. For venous thrombotic (VTC) complications and arterial thrombotic complications alone, these numbers were, respectively, 3.6% (95% CI, 2.7–4.6) and 7.5% (95% CI, 6.3–8.8) in influenza versus 23% (95% CI, 16–29) and 4.4% (95% CI, 1.9–8.8) in COVID‐19. CONCLUSIONS: The incidence of thrombotic complications in hospitalized patients with influenza was lower than in hospitalized patients with COVID‐19. This difference was mainly driven by a high risk of VTC complications in the patients with COVID‐19 admitted to the Intensive Care Unit. Remarkably, patients with influenza were more often diagnosed with arterial thrombotic complications. [Image: see text]
format Online
Article
Text
id pubmed-8014477
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-80144772021-04-01 Risk of thrombotic complications in influenza versus COVID‐19 hospitalized patients Stals, Milou A. M. Grootenboers, Marco J. J. H. van Guldener, Coen Kaptein, Fleur H. J. Braken, Sander J. E. Chen, Qingui Chu, Gordon van Driel, Erik M. Iglesias del Sol, Antonio de Jonge, Evert Kant, K. Merijn Pals, Fleur Toorop, Myrthe M. A. Cannegieter, Suzanne C. Klok, Frederikus A. Huisman, Menno V. Res Pract Thromb Haemost Original Articles ‐ Thrombosis BACKGROUND: Whereas accumulating studies on patients with coronavirus disease 2019 (COVID‐19) report high incidences of thrombotic complications, large studies on clinically relevant thrombosis in patients with other respiratory tract infections are lacking. How this high risk in COVID‐19 patients compares to those observed in hospitalized patients with other viral pneumonias such as influenza is unknown. OBJECTIVES: To assess the incidence of venous and arterial thrombotic complications in hospitalized patients with influenza as opposed to that observed in hospitalized patients with COVID‐19. METHODS: This was a retrospective cohort study; we used data from Statistics Netherlands (study period: 2018) on thrombotic complications in hospitalized patients with influenza. In parallel, we assessed the cumulative incidence of thrombotic complications—adjusted for competing risk of death—in patients with COVID‐19 in three Dutch hospitals (February 24 to April 26, 2020). RESULTS: Of the 13 217 hospitalized patients with influenza, 437 (3.3%) were diagnosed with thrombotic complications, versus 66 (11%) of the 579 hospitalized patients with COVID‐19. The 30‐day cumulative incidence of any thrombotic complication in influenza was 11% (95% confidence interval [CI], 9.4–12) versus 25% (95% CI, 18–32) in COVID‐19. For venous thrombotic (VTC) complications and arterial thrombotic complications alone, these numbers were, respectively, 3.6% (95% CI, 2.7–4.6) and 7.5% (95% CI, 6.3–8.8) in influenza versus 23% (95% CI, 16–29) and 4.4% (95% CI, 1.9–8.8) in COVID‐19. CONCLUSIONS: The incidence of thrombotic complications in hospitalized patients with influenza was lower than in hospitalized patients with COVID‐19. This difference was mainly driven by a high risk of VTC complications in the patients with COVID‐19 admitted to the Intensive Care Unit. Remarkably, patients with influenza were more often diagnosed with arterial thrombotic complications. [Image: see text] John Wiley and Sons Inc. 2021-04-08 /pmc/articles/PMC8014477/ /pubmed/33821230 http://dx.doi.org/10.1002/rth2.12496 Text en © 2021 The Authors. Research and Practice in Thrombosis and Haemostasis published by Wiley Periodicals LLC on behalf of International Society on Thrombosis and Haemostasis (ISTH). https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Original Articles ‐ Thrombosis
Stals, Milou A. M.
Grootenboers, Marco J. J. H.
van Guldener, Coen
Kaptein, Fleur H. J.
Braken, Sander J. E.
Chen, Qingui
Chu, Gordon
van Driel, Erik M.
Iglesias del Sol, Antonio
de Jonge, Evert
Kant, K. Merijn
Pals, Fleur
Toorop, Myrthe M. A.
Cannegieter, Suzanne C.
Klok, Frederikus A.
Huisman, Menno V.
Risk of thrombotic complications in influenza versus COVID‐19 hospitalized patients
title Risk of thrombotic complications in influenza versus COVID‐19 hospitalized patients
title_full Risk of thrombotic complications in influenza versus COVID‐19 hospitalized patients
title_fullStr Risk of thrombotic complications in influenza versus COVID‐19 hospitalized patients
title_full_unstemmed Risk of thrombotic complications in influenza versus COVID‐19 hospitalized patients
title_short Risk of thrombotic complications in influenza versus COVID‐19 hospitalized patients
title_sort risk of thrombotic complications in influenza versus covid‐19 hospitalized patients
topic Original Articles ‐ Thrombosis
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8014477/
https://www.ncbi.nlm.nih.gov/pubmed/33821230
http://dx.doi.org/10.1002/rth2.12496
work_keys_str_mv AT stalsmilouam riskofthromboticcomplicationsininfluenzaversuscovid19hospitalizedpatients
AT grootenboersmarcojjh riskofthromboticcomplicationsininfluenzaversuscovid19hospitalizedpatients
AT vanguldenercoen riskofthromboticcomplicationsininfluenzaversuscovid19hospitalizedpatients
AT kapteinfleurhj riskofthromboticcomplicationsininfluenzaversuscovid19hospitalizedpatients
AT brakensanderje riskofthromboticcomplicationsininfluenzaversuscovid19hospitalizedpatients
AT chenqingui riskofthromboticcomplicationsininfluenzaversuscovid19hospitalizedpatients
AT chugordon riskofthromboticcomplicationsininfluenzaversuscovid19hospitalizedpatients
AT vandrielerikm riskofthromboticcomplicationsininfluenzaversuscovid19hospitalizedpatients
AT iglesiasdelsolantonio riskofthromboticcomplicationsininfluenzaversuscovid19hospitalizedpatients
AT dejongeevert riskofthromboticcomplicationsininfluenzaversuscovid19hospitalizedpatients
AT kantkmerijn riskofthromboticcomplicationsininfluenzaversuscovid19hospitalizedpatients
AT palsfleur riskofthromboticcomplicationsininfluenzaversuscovid19hospitalizedpatients
AT tooropmyrthema riskofthromboticcomplicationsininfluenzaversuscovid19hospitalizedpatients
AT cannegietersuzannec riskofthromboticcomplicationsininfluenzaversuscovid19hospitalizedpatients
AT klokfrederikusa riskofthromboticcomplicationsininfluenzaversuscovid19hospitalizedpatients
AT huismanmennov riskofthromboticcomplicationsininfluenzaversuscovid19hospitalizedpatients
AT riskofthromboticcomplicationsininfluenzaversuscovid19hospitalizedpatients